Vishal S Vaidya, Ph.D.

Vishal S Vaidya, Ph.D.

Harvard University

H-index: 54

North America-United States

About Vishal S Vaidya, Ph.D.

Vishal S Vaidya, Ph.D., With an exceptional h-index of 54 and a recent h-index of 35 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Kidney Biology, Toxicology, Biomarkers.

His recent articles reflect a diverse array of research interests and contributions to the field:

Treatment methods for fibrosis targeting SMOC2

Thymic lymphoma detection in RORγ knockout mice using 5-hydroxymethylcytosine profiling of circulating cell-free DNA

Harihara M. Mehendale: A Life Dedicated to Mentoring and Research

Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humans

Circulating neurofilament light chain as a promising biomarker of AAV-induced dorsal root ganglia toxicity in nonclinical toxicology species

Therapeutic silencing of SMOC2 prevents kidney function loss in mouse model of chronic kidney disease

A biomarker-centric approach to drug discovery and development: lessons learned from the coronavirus disease 2019 pandemic

Safety and disease monitoring biomarkers in Duchenne muscular dystrophy: results from a Phase II trial

Vishal S Vaidya, Ph.D. Information

University

Position

Harvard Medical School

Citations(all)

12901

Citations(since 2020)

4077

Cited By

10316

hIndex(all)

54

hIndex(since 2020)

35

i10Index(all)

90

i10Index(since 2020)

71

Email

University Profile Page

Harvard University

Google Scholar

View Google Scholar Profile

Vishal S Vaidya, Ph.D. Skills & Research Interests

Kidney Biology

Toxicology

Biomarkers

Top articles of Vishal S Vaidya, Ph.D.

Title

Journal

Author(s)

Publication Date

Treatment methods for fibrosis targeting SMOC2

2024/2/20

Thymic lymphoma detection in RORγ knockout mice using 5-hydroxymethylcytosine profiling of circulating cell-free DNA

Toxicology and Applied Pharmacology

Kelly A Fader

Mark M Gosink

Shuhua Xia

Thomas A Lanz

Charles Halsey

...

2023/8/15

Harihara M. Mehendale: A Life Dedicated to Mentoring and Research

International Journal of Toxicology

Udayan Apte

S Satheesh Anand

Murali Badanthadka

Jaya Chilakapati

Lawrence R Curtis

...

2023/8

Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humans

Nature communications

Kodihalli C Ravindra

Vishal S Vaidya

Zhenyu Wang

Joel D Federspiel

Richard Virgen-Slane

...

2023/3/3

Circulating neurofilament light chain as a promising biomarker of AAV-induced dorsal root ganglia toxicity in nonclinical toxicology species

Molecular Therapy-Methods & Clinical Development

Kelly A Fader

Ingrid D Pardo

Ramesh C Kovi

Christopher J Somps

Helen Hong Wang

...

2022/6/9

Therapeutic silencing of SMOC2 prevents kidney function loss in mouse model of chronic kidney disease

Iscience

Cuiyan Xin

Jiahui Lei

Qian Wang

Yixia Yin

Xiaoqian Yang

...

2021/10/22

A biomarker-centric approach to drug discovery and development: lessons learned from the coronavirus disease 2019 pandemic

Kelly A Fader

Jiangwei Zhang

Joseph P Menetski

Ravi I Thadhani

Elliott M Antman

...

2021/1/1

Safety and disease monitoring biomarkers in Duchenne muscular dystrophy: results from a Phase II trial

Biomarkers in Medicine

Kathryn R Wagner

Michaela Guglieri

Shashi K Ramaiah

Lawrence Charnas

Shannon Marraffino

...

2021/10

P041 Tandem mass tag-based quantitative proteomic profiling identifies novel putative serum biomarkers for the diagnosis of drug-induced liver injury in patients

Ravi Kodihalli

Vishal Vaidya

Zhenyu Wang

Joel Federspiel

Richard Virgen-Slane

...

2021/9/1

Cadherin-11, Sparc-related modular calcium binding protein-2, and Pigment epithelium-derived factor are promising non-invasive biomarkers of kidney fibrosis

Kidney international

Insa M Schmidt

Mia R Colona

Bryan R Kestenbaum

Leonidas G Alexopoulos

Ragnar Palsson

...

2021/9/1

Evaluating the sensitivity and specificity of promising circulating biomarkers to diagnose liver injury in humans

Toxicological Sciences

Heather P Llewellyn

Vishal S Vaidya

Zhenyu Wang

Qinghai Peng

Craig Hyde

...

2021/5/1

Tissue-engineered human myobundle system as a platform for evaluation of skeletal muscle injury biomarkers

Toxicological Sciences

Alastair Khodabukus

Amulya Kaza

Jason Wang

Neel Prabhu

Richard Goldstein

...

2020/7

Methods for the treatment of kidney fibrosis

2020/2/11

See List of Professors in Vishal S Vaidya, Ph.D. University(Harvard University)